Female Reproductive

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC18-3

DiraChart Clinical Reference
Protected section 3 of 25
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 3 of 25PreviousNext

2. What the clinician must assess

A complete female genitourinary assessment addresses each of the following as indicated by the patient’s condition and orders, performed with consent, privacy, and a chaperone per policy, and compares each finding to baseline.

  • Vaginal bleeding or discharge — amount, character, and — critically — any bleeding after menopause, which is treated as malignancy until excluded.
  • Pelvic pain — its character, severity, and acuity, and any associated fever.
  • Post-operative gynecologic status — the surgical site or vaginal cuff after hysterectomy or other gynecologic surgery, and the signs of bleeding, infection, or dehiscence.
  • Pelvic-floor and prolapse status — the degree of prolapse, symptoms, and the effect on voiding and bowel function.
  • Pessary status where present — position, comfort, discharge, and the signs of erosion or retention.
  • Vulvar and perineal skin — briefly, with the detailed skin exam documented in External Genitalia.
  • Infection signs — local and systemic, including the perineal signs that can indicate a necrotizing infection.
  • Urinary and bowel symptoms as they relate to prolapse or a fistula (bladder detail in Urinary/Renal).
  • Vital signs where bleeding or infection is present, including for hemodynamic change with heavy bleeding.
  • The patient’s adherence to post-operative instructions and pessary or pelvic-floor care.
Section NavigationPart 3 of 25PreviousNext